Hiroaki Shigeta
Keine laufenden Positionen mehr
Karriereverlauf von Hiroaki Shigeta
Ehemalige bekannte Positionen von Hiroaki Shigeta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MEDICINOVA, INC. | Direktor/Vorstandsmitglied | 16.09.2009 | 11.06.2015 |
| Independent Dir/Board Member | 14.09.2009 | 11.06.2015 | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Direktor/Vorstandsmitglied | 01.10.1993 | 01.12.2004 |
| Corporate Officer/Principal | 01.01.2003 | 01.12.2004 | |
| CHUGAI PHARMACEUTICAL CO., LTD | Direktor/Vorstandsmitglied | 01.06.2002 | 01.04.2003 |
Nippon Roche KK
 Nippon Roche KK Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Nippon Roche KK is a Japanese company that manufactures and sells pharmaceuticals. The company is based in Tokyo, Japan. Nippon Roche KK was acquired by Chugai Pharmaceutical Co., Ltd. from Roche Holding AG on October 01, 2002 for $1,613.74 million. | Vorstandsvorsitzender | 01.10.1993 | 01.12.2000 |
| Vorsitzender | 01.01.2001 | 01.05.2002 | |
| Präsident | 01.10.1993 | 01.12.2000 | |
| THE MEDICINES COMPANY | Direktor/Vorstandsmitglied | 09.04.2007 | - |
| Independent Dir/Board Member | 09.04.2007 | - |
Ausbildung von Hiroaki Shigeta
| Momoyama Gakuin University | Undergraduate Degree |
| Haas School of Business | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Japan | 4 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDICINOVA, INC. | Health Technology |
| CHUGAI PHARMACEUTICAL CO., LTD | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Nippon Roche KK
Nippon Roche KK Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Nippon Roche KK is a Japanese company that manufactures and sells pharmaceuticals. The company is based in Tokyo, Japan. Nippon Roche KK was acquired by Chugai Pharmaceutical Co., Ltd. from Roche Holding AG on October 01, 2002 for $1,613.74 million. | Health Technology |
- Börse
- Insiders
- Hiroaki Shigeta
- Erfahrung
